Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children.

@article{Douglas1984VaccinationAS,
  title={Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children.},
  author={Robert M. Douglas and H B Miles},
  journal={The Journal of infectious diseases},
  year={1984},
  volume={149 6},
  pages={861-9}
}
A double-blind, randomized, controlled trial of a 14-valent Streptococcus pneumoniae polysaccharide vaccine, with saline as placebo, was performed on 1,273 healthy children six to 54 months of age. Different dosage regimens were used for children younger and older than two years of age. The vaccine was well tolerated. Follow-up continued for two years… CONTINUE READING